It is also able to induce the expression of Nrf-2 [43] and to competitively inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), a feature that is especially attractive for AD patient treatment [57]. Here, ACHE is linked to Alzheimer disease.